Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nutt

Showing results (91-100 of 179) with videos related to

Pageof 18
Sort By:
Neuropharmacology|September 8, 2014
Differences between magnetoencephalographic (MEG) spectral profiles of drugs acting on GABA at synaptic and extrasynaptic sites: a study in healthy volunteersDavid Nutt, Sue Wilson, Anne Lingford-Hughes, et al.
The Health Service Journal|January 19, 2012
Patient access. How to wipe out a growing killerKosh Agarwal, David Badcock, Owen Bowden-Jones, et al.
Psychological Medicine|January 22, 2024
Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depressionBalázs Szigeti, Brandon Weiss, Fernando E Rosas, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 28, 2019
Alcohol Hangover: Underlying Biochemical, Inflammatory and Neurochemical MechanismsEmily Palmer, Robin Tyacke, Magdalena Sastre, et al.
Journal of Psychopharmacology (Oxford, England)|November 12, 2024
Promising strategies for the prevention of alcohol-related brain damage through optimised management of acute alcohol withdrawal: A focussed literature reviewDarren Quelch, Anne Lingford-Hughes, Bev John, et al.
Toxicology and Applied Pharmacology|February 8, 2017
Toxicological evaluation of 5-methoxy-2-aminoindane (MEAI): Binge mitigating agent in developmentJakob A Shimshoni, Ilan Winkler, Nir Edery, et al.
The International Journal on Drug Policy|February 28, 2021
A multi criteria decision analysis (MCDA) for evaluating and appraising government policy responses to non medical heroin useSteve Rolles, Anne Katrin Schlag, Fiona Measham, et al.
Drug and Alcohol Dependence|February 6, 2021
Functional evaluation of NK<sub>1</sub> antagonism on cue reactivity in opiate dependence; An fMRI studyLeon Fonville, Louise Paterson, Katherine Herlinger, et al.
The Lancet. Neurology|March 3, 2015
Building bridges between neuroscientific evidence and policyGianluca Quaglio, Mairead McGuinness, Paul Rübig, et al.
BMJ (Clinical Research Ed.)|October 1, 2017
Is the UK's 2017 drug strategy fit for purpose?Chris Ford, David Nutt, Niamh Eastwood, et al.
Pageof 18

Showing results (91-100 of 179) with videos related to

Sort By:
Pageof 18
Neuropharmacology|September 8, 2014
Differences between magnetoencephalographic (MEG) spectral profiles of drugs acting on GABA at synaptic and extrasynaptic sites: a study in healthy volunteersDavid Nutt, Sue Wilson, Anne Lingford-Hughes, et al.
The Health Service Journal|January 19, 2012
Patient access. How to wipe out a growing killerKosh Agarwal, David Badcock, Owen Bowden-Jones, et al.
Psychological Medicine|January 22, 2024
Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depressionBalázs Szigeti, Brandon Weiss, Fernando E Rosas, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 28, 2019
Alcohol Hangover: Underlying Biochemical, Inflammatory and Neurochemical MechanismsEmily Palmer, Robin Tyacke, Magdalena Sastre, et al.
Journal of Psychopharmacology (Oxford, England)|November 12, 2024
Promising strategies for the prevention of alcohol-related brain damage through optimised management of acute alcohol withdrawal: A focussed literature reviewDarren Quelch, Anne Lingford-Hughes, Bev John, et al.
Toxicology and Applied Pharmacology|February 8, 2017
Toxicological evaluation of 5-methoxy-2-aminoindane (MEAI): Binge mitigating agent in developmentJakob A Shimshoni, Ilan Winkler, Nir Edery, et al.
The International Journal on Drug Policy|February 28, 2021
A multi criteria decision analysis (MCDA) for evaluating and appraising government policy responses to non medical heroin useSteve Rolles, Anne Katrin Schlag, Fiona Measham, et al.
Drug and Alcohol Dependence|February 6, 2021
Functional evaluation of NK<sub>1</sub> antagonism on cue reactivity in opiate dependence; An fMRI studyLeon Fonville, Louise Paterson, Katherine Herlinger, et al.
The Lancet. Neurology|March 3, 2015
Building bridges between neuroscientific evidence and policyGianluca Quaglio, Mairead McGuinness, Paul Rübig, et al.
BMJ (Clinical Research Ed.)|October 1, 2017
Is the UK's 2017 drug strategy fit for purpose?Chris Ford, David Nutt, Niamh Eastwood, et al.
Pageof 18